KEGG   DRUG: Pidilizumab
Entry
D10390                      Drug                                   
Name
Pidilizumab (USAN)
Formula
C6424H9920N1704O2002S48
Exact mass
144503.3409
Mol weight
144592.8372
Class
Antineoplastic
 DG02938  Immune checkpoint inhibitor
Efficacy
Antineoplastic, Anti-PD-1 antibody
Comment
Monoclonal antibody
Treatment of cancer and infectious diseases
Target
PDCD1 (PD1, CD279) [HSA:5133] [KO:K06744]
  Pathway
hsa04514  Cell adhesion molecules
hsa04660  T cell receptor signaling pathway
hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer
Brite
Drug groups [BR:br08330]
 Antineoplastic
  DG02938  Immune checkpoint inhibitor
   D10390  Pidilizumab
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   Immune checkpoints
    PDCD1 (PD1, CD279)
     D10390  Pidilizumab (USAN)
Other DBs
CAS: 1036730-42-3
PubChem: 172232483
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system